1. Jiao, Yu-Rui, Wang, Wei, Lei, Peng-Cheng, Wang, Ya-Feng, Zhu, Yi-Kun. 2018. 5-HTT, BMPR2, EDN1, ENG, KCNA5 gene polymorphisms and susceptibility to pulmonary arterial hypertension: A meta-analysis. In Gene, 680, 34-42. doi:10.1016/j.gene.2018.09.020. https://pubmed.ncbi.nlm.nih.gov/30218748/
2. Tian, Li, Liu, Gang, Wang, Le, Zheng, Mingqi, Li, Yongjun. 2015. KCNA5 gene polymorphism associate with idiopathic atrial fibrillation. In International journal of clinical and experimental medicine, 8, 9890-6. doi:. https://pubmed.ncbi.nlm.nih.gov/26309673/
3. Bossini-Castillo, Lara, Simeon, Carmen P, Beretta, Lorenzo, Fonseca, Carmen, Martin, Javier. 2012. KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor. In Arthritis research & therapy, 14, R273. doi:10.1186/ar4124. https://pubmed.ncbi.nlm.nih.gov/23270786/
4. Qu, Chao, Sun, Jia, Liu, Ying, Zou, Wei, Liu, Jing. 2018. Caveolin-1 facilitated KCNA5 expression, promoting breast cancer viability. In Oncology letters, 16, 4829-4838. doi:10.3892/ol.2018.9261. https://pubmed.ncbi.nlm.nih.gov/30250548/
5. Wipff, J, Dieudé, P, Guedj, M, Boileau, C, Allanore, Y. . Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population. In Arthritis and rheumatism, 62, 3093-100. doi:10.1002/art.27607. https://pubmed.ncbi.nlm.nih.gov/20556823/
6. Brevnova, Elena E, Platoshyn, Oleksandr, Zhang, Shen, Yuan, Jason X-J. 2004. Overexpression of human KCNA5 increases IK V and enhances apoptosis. In American journal of physiology. Cell physiology, 287, C715-22. doi:. https://pubmed.ncbi.nlm.nih.gov/15140747/
7. Eichstaedt, Christina A, Saßmannshausen, Zoe, Shaukat, Memoona, Hinderhofer, Katrin, Grünig, Ekkehard. 2022. Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension. In Respiratory research, 23, 74. doi:10.1186/s12931-022-01987-x. https://pubmed.ncbi.nlm.nih.gov/35346192/
智鼠故事 
